The GLP-1 class has now demonstrated durable weight loss, cardiovascular benefit, and increasingly effects across metabolic disease beyond obesity
It is a micronutrient that the bodyrequires for the metabolism of thyroid hormones
Additionally, the study reported lower all-cause mortality among GLP-1 users, which, while encouraging, complicates interpretation of the dementia findings patients who live longer may simply have more time to develop cognitive symptoms
Sixty-six per cent provide coverage for GLP-1 drugs for diabetes only, while 17 per cent provide coverage for both diabetes and weight loss, according to a recent survey from the International Foundation of Employee Benefit Plans
To our knowledge, sweeteners and common xenobiotics have not been tested systematically for combinatory effects on human gut bacteria, which can be highly relevant as exemplified by multi-antibiotic-resistance phenotype in E
doi: 10.1016/j.pharmthera.2012.08.001 63 KianderWSjstedtNManninenRJaakkonenLVellonenK-SNeuvonenMet al